Edition:
United States

ArQule Inc (ARQL.OQ)

ARQL.OQ on NASDAQ Stock Exchange Global Market

1.55USD
18 Jan 2017
Change (% chg)

-- (--)
Prev Close
$1.55
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
17,089
52-wk High
$2.17
52-wk Low
$1.20

ARQL.OQ

Chart for ARQL.OQ

About

ArQule, Inc. is a biopharmaceutical company. The Company is engaged in the research and development of therapeutics to treat cancers and rare diseases. These drugs focuses on the biological pathways implicated in a range of cancers and certain non-oncology indications. Its clinical-stage pipeline consists of over four drug... (more)

Overall

Beta: 1.47
Market Cap(Mil.): $110.23
Shares Outstanding(Mil.): 71.12
Dividend: --
Yield (%): --

Financials

  ARQL.OQ Industry Sector
P/E (TTM): -- 45.86 30.46
EPS (TTM): -0.27 -- --
ROI: -60.96 -1.27 14.82
ROE: -60.96 -1.00 16.24

BRIEF-Arqule Q3 loss $0.08/shr

* Q3 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Nov 07 2016

BRIEF-Arqule enters into capital on demand sales agreement with Jonestrading Institutional Services LLC on Oct. 25

* Arqule- On October 25, 2016, co entered into a capital on demand!" sales agreement with Jonestrading Institutional Services LLC - sec filing

Oct 26 2016

BRIEF-Arqule Inc files for mixed shelf of upto $100 million - SEC filing

* Files for mixed shelf of upto $100 million - SEC filing Source: (http://bit.ly/2bJGGEw) Further company coverage:

Sep 02 2016

BRIEF-Arqule Q2 loss per share $0.07

* Q2 earnings per share view $-0.08 -- Thomson Reuters I/B/E/S

Aug 03 2016

Earnings vs. Estimates